PMV Pharmaceuticals, (id:8227 PMVP)
1.61 USD
Opening hours: 09:30 - 16:00 (Eastern Standard Time: 11/24/2024 5:45:58 PM)
Exchange closed, opens in 15 hours 44 minutes
0.00 USD (0.00%)
0.00 USD (0.00%)
5.92 USD (5.92%)
-20.69 USD (-20.69%)
-29.07 USD (-29.07%)
-95.40 USD (-95.40%)
About PMV Pharmaceuticals,
Market Capitalization 80.73M
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. It's lead product candidate is PC14586, a small molecule that corrects mutant p53 protein containing the Y220C mutation and restores wild-type p53 function. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is based in Princeton, New Jersey.
| Headquarters (address) |
1 Research Way Princeton 08540 NJ United States |
| Phone | 609 642 6670 |
| Website | https://www.pmvpharma.com |
| Employees | 63 |
| Sector | Healthcare |
| Industry | Biotechnology |
| Ticker | PMVP |
| Exchange | NASDAQ Stock Exchange |
| Currency | USD |
| 52 week range | 1.40 - 3.47 |
| Market Capitalization | 80.73M |
| P/E trailing | -1.12 |
| P/E forward | -0.987 |
| Price/Book | 0.408 |
| Beta | 1.48 |
| EPS | -1.00 |
| EPS United States (ID:6, base:3402) | 24.22 |